Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline includes Lenzetto, Evamist, Testosterone Topical Solution, and others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    36

Stocks News & Analysis

stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks

Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27

Charts from the Australian Dividend Outlook show the sectors where they are abundant.
stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,276.6019.90-0.21%
CAC 408,041.3618.77-0.23%
DAX 4024,611.2514.120.06%
Dow JONES (US)46,352.40249.38-0.54%
FTSE 1009,509.4039.47-0.41%
HKSE26,752.5976.87-0.29%
NASDAQ22,953.8189.57-0.39%
Nikkei 22548,580.44845.451.77%
NZX 50 Index13,570.862.380.02%
S&P 5006,725.6428.08-0.42%
S&P/ASX 2008,969.8025.20-0.28%
SSE Composite Index3,933.9751.201.32%

Market Movers